Role of immunomodulators in allergen-specific immunotherapy
M. V. Kopp.
Allergy Vol. 66 (3). Published online: 18 FEB 2011.

The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy
P. Devillier, M. Le Gall and F. Horak
Allergy Volume 66, Issue 2, pages 163–169, February 2011

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials
S. R. Durham, A. O. Birk and J. S. Andersen
Allergy Volume 66, Issue 1, pages 120–123, January 2011

Patient characteristics associated with allergen immunotherapy initiation and adherence
Cheryl S. Hankin, Richard F. Lockey
Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 46-48, January 2011

The impact of molecular biology on allergen immunotherapy
Bush, Robert K
Current Opinion in Allergy & Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 557–558

Functional regulatory T cells and allergen immunotherapy
Rolland, Jennifer M; Gardner, Leanne M; O’Hehir, Robyn E
Current Opinion in Allergy and Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 559–566
Acceso Libre

The current state of recombinant allergens for immunotherapy
Pauli, Gabrielle; Malling, H-J
Current Opinion in Allergy & Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 575–581